EUVIMEDEUVIMED entdecken
Crossref

Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?

Rachita S Dhurat, Richa Sharma, Archi Ranka, Grishma Kale

Cosmoderma · 18.07.2026 · 6 · 86

DOI: 10.25259/csdm_94_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cosmoderma, online erschienen am 18.07.2026. Verfasst von Rachita S Dhurat und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dhurat, R. S., Sharma, R., Ranka, A., & Kale, G. (2026). Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma, 6, 86. https://doi.org/10.25259/csdm_94_2026

Vancouver

Dhurat RS, Sharma R, Ranka A, Kale G. Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma. 2026;6:86. doi:10.25259/csdm_94_2026

BibTeX
@article{Dhurat2026,
  author = {Dhurat, Rachita S and Sharma, Richa and Ranka, Archi and Kale, Grishma},
  title = {Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?},
  journal = {Cosmoderma},
  year = {2026},
  volume = {6},
  pages = {86},
  doi = {10.25259/csdm_94_2026}
}
Kostenlos starten →